755 results on '"Bedford, Mark T"'
Search Results
2. Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
3. Functional characterization of QT interval associated SCN5A enhancer variants identify combined additive effects
4. Affinity purification mass spectrometry characterisation of the interactome of receptor tyrosine kinase proline-rich motifs in cancer
5. Targeting of CYP2E1 by miRNAs in alcohol-induced intestine injury
6. Molecular Basis for SPINDOC-Spindlin1 Engagement and Its Role in Transcriptional Attenuation
7. The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer
8. CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth
9. CARM1 arginine methyltransferase as a therapeutic target for cancer
10. Reprogramming CBX8-PRC1 function with a positive allosteric modulator
11. Mature microRNA-binding protein QKI suppresses extracellular microRNA let-7b release.
12. A small molecule antagonist of SMN disrupts the interaction between SMN and RNAP II
13. Affinity purification mass spectrometry characterization of the interactome of receptor tyrosine kinase proline rich motifs in cancer
14. Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation
15. Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferases
16. Exploring the PDZ, DUF, and LIM Domains of Pdlim5 in Dendrite Branching.
17. Functional characterization of QT interval associatedSCN5Aenhancer variants identify combined additive effects
18. CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas
19. Increased Susceptibility to Skin Carcinogenesis Associated with a Spontaneous Mouse Mutation in the Palmitoyl Transferase Zdhhc13 Gene.
20. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2*
21. SPINDOC binds PARP1 to facilitate PARylation
22. Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7
23. Arginine Methylation Facilitates the Recruitment of TOP3B to Chromatin to Prevent R Loop Accumulation
24. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition
25. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma
26. Molecular basis for SPINDOC-Spindlin1 engagement and its role in transcriptional attenuation
27. SART3 reads methylarginine-marked glycine- and arginine-rich motifs
28. Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-rich Regions*
29. Recognition of Histone H3 Lysine-4 Methylation by the Double Tudor Domain of JMJD2A
30. Specific Protein Methylation Defects and Gene Expression Perturbations in Coactivator-Associated Arginine Methyltransferase 1-Deficient Mice
31. PRMT5 promotes DNA repair through methylation of 53BP1 and is regulated by Src-mediated phosphorylation
32. Phosphorylation of Connexin36 near the C-terminus switches binding affinities for PDZ-domain and 14–3–3 proteins in vitro
33. The histone and non-histone methyllysine reader activities of the UHRF1 tandem Tudor domain are dispensable for the propagation of aberrant DNA methylation patterning in cancer cells
34. Author Correction: De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens
35. Characterization of the plant homeodomain (PHD) reader family for their histone tail interactions
36. Methylarginine Recognition by Tudor Domains
37. WW Domain-Mediated Interactions Reveal a Spliceosome-Associated Protein that Binds a Third Class of Proline-Rich Motif: The Proline Glycine and Methionine-Rich Motif
38. Abstract LB182: Targeting arginine methylation for improved therapy in triple negative breast cancer
39. Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
40. Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
41. Data from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
42. Effectors and effects of arginine methylation
43. Supplementary Table 2 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
44. Supplementary Table 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
45. Data from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
46. Supplementary Figure 1 from PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated Macrophages
47. E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair
48. De novo identification of essential protein domains from CRISPR-Cas9 tiling-sgRNA knockout screens
49. Supplementary Figure 8 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
50. Supplementary Figure 7 from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.